Last 48 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Globus Medical, Inc.'s quarterly P/E stands at 23.9x, down 29.4% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 18.8% YoY to 12.3x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 20.21 | 23.93 | 21.61 | 16.27 | 9.90 | 33.89 | 108.83 | 47.07 | 74.45 | — | 121.11 | 1426.72 | 26.11 |
| — | -29.4% | -80.1% | -65.4% | -86.7% | — | -10.1% | -96.7% | +185.1% | — | +219.6% | +4402.7% | -1.4% | |
| P/S Ratio | 3.64 | 3.92 | 3.62 | 2.52 | 2.70 | 4.28 | 4.40 | 3.95 | 3.72 | 2.99 | 3.00 | 3.73 | 5.20 |
| — | -8.4% | -17.5% | -36.1% | -27.5% | +42.9% | +46.3% | +5.8% | -28.3% | -42.8% | -56.5% | -37.3% | -5.1% | |
| P/B Ratio | 2.38 | 2.52 | 2.62 | 1.76 | 1.88 | 2.50 | 2.77 | 2.43 | 2.36 | 1.85 | 1.85 | 1.37 | 3.05 |
| — | +0.5% | -5.3% | -27.4% | -20.5% | +35.2% | +49.3% | +77.6% | -22.7% | -38.8% | -54.9% | -60.1% | -10.2% | |
| P/FCF | 18.15 | 18.29 | 15.57 | 8.86 | 64.34 | 18.78 | 14.95 | 15.27 | 88.64 | 76.21 | 22.64 | 49.41 | 88.29 |
| — | -2.6% | +4.1% | -42.0% | -27.4% | -75.4% | -34.0% | -69.1% | +0.4% | +96.5% | -45.5% | -31.5% | -19.7% | |
| EV / EBITDA | 17.14 | 12.27 | 11.96 | 9.10 | 13.54 | 15.12 | 22.00 | 21.27 | 20.98 | 29.37 | 22.95 | 39.46 | 17.07 |
| — | -18.8% | -45.7% | -57.2% | -35.5% | -48.5% | -4.1% | -46.1% | +22.9% | +57.1% | -12.6% | +106.5% | +2.8% | |
| EV / EBIT | 21.42 | 17.52 | 16.62 | 13.02 | 16.18 | 25.14 | 36.69 | 49.95 | 37.83 | 62.86 | 71.87 | 30.46 | 20.79 |
| — | -30.3% | -54.7% | -73.9% | -57.2% | -60.0% | -49.0% | +63.9% | +81.9% | +160.7% | +138.7% | +21.8% | -1.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Globus Medical, Inc.'s operating margin was 21.5% in Q1 2026, up 0.8 pp QoQ and up 5.3 pp YoY. This marks the 4th consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 17.5% lags the current quarter, suggesting the recent improvement is above-trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.4% | 69.2% | 72.0% | 63.3% | 66.6% | 67.3% | 59.9% | 56.8% | 58.7% | 60.2% | 56.9% | 64.7% | 73.8% |
| — | +2.8% | +20.2% | +11.5% | +13.5% | +11.9% | +5.2% | -12.3% | -20.4% | -19.1% | -23.3% | -12.8% | -0.3% | |
| Operating Margin | 16.3% | 21.5% | 20.8% | 17.6% | 10.2% | 16.2% | 9.2% | 7.7% | 7.9% | 1.3% | 1.6% | 0.1% | 22.7% |
| — | +32.7% | +126.5% | +128.4% | +29.6% | +1130.3% | +458.5% | +7200.1% | -65.3% | -93.5% | -91.7% | -99.6% | -11.7% | |
| Net Margin | 18.3% | 16.4% | 17.0% | 15.5% | 27.2% | 12.6% | 4.0% | 8.3% | 5.0% | -1.2% | 2.4% | 0.3% | 19.8% |
| — | +29.7% | +322.0% | +86.7% | +439.6% | +1175.5% | +65.4% | +3085.1% | -74.5% | -106.6% | -86.6% | -98.6% | -4.4% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 12.3% | 2.7% | 3.1% | 2.7% | 4.8% | 1.8% | 0.6% | 1.3% | 0.8% | -0.2% | 0.4% | 0.0% | 3.0% |
| — | +46.3% | +387.7% | +112.4% | +501.7% | +1116.1% | +75.0% | +3889.2% | -72.8% | -106.9% | -86.8% | -98.8% | -5.5% | |
| ROA | 10.2% | 2.3% | 2.7% | 2.4% | 4.2% | 1.5% | 0.5% | 1.0% | 0.6% | -0.1% | 0.3% | 0.0% | 2.6% |
| — | +52.8% | +427.5% | +130.0% | +556.2% | +1167.6% | +78.1% | +3795.8% | -75.8% | -106.1% | -88.3% | -98.9% | -5.2% | |
| ROIC | 8.9% | 2.9% | 3.1% | 2.4% | 1.4% | 1.9% | 1.1% | 0.9% | 0.9% | 0.1% | 0.2% | 0.0% | 2.9% |
| — | +52.6% | +171.1% | +172.0% | +58.9% | +1191.4% | +538.4% | +8923.2% | -69.1% | -94.1% | -92.6% | -99.6% | -10.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Globus Medical, Inc.'s Debt/EBITDA ratio is 0.5x — comfortably within a safe range. Debt/Equity has declined for 4 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 | — |
| — | +7.8% | -79.8% | -79.3% | -78.8% | -83.1% | -1.2% | +5.2% | — | — | +3897.8% | — | — | |
| Debt / EBITDA | 0.20 | 0.49 | 0.49 | 0.58 | 0.83 | 0.57 | 4.18 | 4.65 | 4.68 | 8.31 | 6.40 | 13.84 | — |
| — | -12.8% | -88.3% | -87.5% | -82.3% | -93.2% | -34.7% | -66.4% | — | — | +7455.5% | — | — | |
| Current Ratio | 4.26 | 4.56 | 4.26 | 4.13 | 4.07 | 4.45 | 2.54 | 2.51 | 2.42 | 2.33 | 4.88 | 4.47 | 7.80 |
| — | +2.5% | +67.6% | +64.3% | +68.1% | +91.2% | -47.9% | -43.8% | -68.9% | -63.6% | -21.0% | -29.4% | +27.7% | |
| Quick Ratio | 2.74 | 2.95 | 2.74 | 2.47 | 2.26 | 2.72 | 1.77 | 1.64 | 1.45 | 1.29 | 2.72 | 2.36 | 5.63 |
| — | +8.6% | +54.5% | +51.2% | +55.3% | +111.3% | -34.8% | -30.7% | -74.2% | -71.2% | -36.7% | -46.2% | +31.6% | |
| Interest Coverage | — | — | — | — | — | — | 94.55 | 63.22 | 26.89 | 15.61 | 10.06 | — | 8.34 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Deep dive into GMED consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GMED stock.
Globus Medical, Inc.'s current P/E is 20.2x. The average P/E over the last 4 quarters is 17.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Globus Medical, Inc.'s current operating margin is 16.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Globus Medical, Inc.'s business trajectory between earnings reports.